Scott Hutton

This profile gathers the share dealings of Scott Hutton in Biodesix Inc, where the filings describe the role as chief executive. We count 23 filings; the first trade dates from 17 November 2021 and the latest from 20 February 2026.

On the open market, the record shows 1 purchase worth €17k and 1 sale worth €6,809. Taken together, the purchases exceed the sales by €10k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 19 option exercises. 2026 to date brings no purchases and 1 sale.

Most recently, on 23 February 2026, the filings show an option exercise in Biodesix Inc. The most recent open-market purchase was published on 18 November 2021, 1,795 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.